Company intelligence / Profile preview
Kodikaz Therapeutic Solutions
New York City, New York, United Stateskodikaz.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Kodikaz is developing a proprietary Zip-Code™ Technology platform that enables targeted, efficient, and flexible delivery of gene therapies to specific cell types without using viral vectors. The company is conducting research trials in multiple oncology indications and aims to overcome the limitations of conventional gene therapy approaches by improving specificity and reducing immune responses. Clinical results are not yet published; programs appear to be in preclinical or early clinical stages[1][3][7][8].
- Therapeutic areas
- OncologyNeurology
- Modalities
- Gene therapies (non-viral delivery)Cell-specific delivery systems[1][8]
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
No major pharmaceutical or biotech partnerships publicly disclosed as of May 2025.
Beyond the preview
Go deeper on Kodikaz Therapeutic Solutions.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kodikaz Therapeutic Solutions.